FindTrial
Sign In

To construct an individualized medication model of recombinant human growth hormone for children with short stature based on machine learning

To construct an individualized medication model of recombinant human growth hormone for children with short stature based on machine learning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073441
Enrollment
Unknown
Registered
2023-07-11
Start date
2023-07-12
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Short stature in children

Interventions

NONE:NONE

Sponsors

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: (1) Meet the criteria for short stature for children (2) In line with the indications of rhGH treatment (3) Continuous treatment with rhGH for =1 year (4) Timely return visit every 3 months, and complete clinical and laboratory data

Exclusion criteria

Exclusion criteria: Data not examined in our hospital

Design outcomes

Primary

MeasureTime frame
IGF-1;IGF-BP3;—

Secondary

MeasureTime frame
Fasting blood glucose;Fasting insulin;HbA1c;—

Countries

China

Contacts

Public ContactLiang Liyang/Wu Junyan

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

liangliy@mail.sysu.edu.cn+86 136 8889 1219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026